45 results on '"Egeberg, Alexander"'
Search Results
2. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
3. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study
4. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa
5. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
6. Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
7. Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study
8. Reduced Skin Microbiome Diversity in Infancy Is Associated with Increased Risk of Atopic Dermatitis in High-Risk Children
9. Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark
10. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
11. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
12. Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysis
13. Infusion of Pituitary Adenylate Cyclase–Activating Polypeptide-38 in Patients with Rosacea Induces Flushing and Facial Edema that Can Be Attenuated by Sumatriptan
14. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study
15. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study
16. Risk of systemic infections in adults with atopic dermatitis: A nationwide cohort study
17. Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis
18. Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis
19. Risk of skin cancer in patients with vitiligo in Denmark: A nationwide cohort study
20. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis
21. The Association Between Season of Birth and Atopic Dermatitis in the Northern Hemisphere: A Systematic Review and Meta-Analysis
22. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark
23. Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis
24. Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis—A Nationwide 20-Year Cohort Study
25. Increased Suicide Risk in Patients with Hidradenitis Suppurativa
26. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
27. Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa
28. Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study)
29. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
30. Machine learning model for predicting outcomes of biologic therapy in psoriasis
31. The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
32. Paradoxical psoriasis after dupilumab treatment of prurigo nodularis successfully treated with adalimumab
33. Prevalence of psoriasis among adults in the US 2009-2010 and 2013-2014 National Health and Nutrition Examination Surveys
34. 41176 Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)
35. 42892 Correlation between DLQI and PASI in patients with psoriasis - a cross-sectional Global Healthcare Study on Psoriasis (GHSP)
36. 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
37. 42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
38. 44115 Integrated Safety Analysis of Abrocitinib in 3802 Patients With Moderate-To-Severe Atopic Dermatitis With Over 5000 Patient-Years of Exposure
39. 41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials
40. 42070 Comparison of COVID-19 Vaccination Rates Among Psoriasis Patients Globally Using the Global Healthcare Study on Psoriasis (GHSP)
41. Birth Outcomes in Children Fathered by Men Treated with Immunosuppressant Drugs before Conception—A Danish Population-Based Cohort Study
42. Reply to: “Comment on ‘Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'”
43. 25442 Relationship between topical corticosteroid utilization and atopic dermatitis severity and burden: A population-based cross-sectional study
44. 26592 Characterization of response clusters identified by unsupervised machine learning: A post hoc analysis of the head-to-head ECLIPSE trial of guselkumab and secukinumab in patients with moderate-to-severe psoriasis
45. Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.